Search - tctmd.com

Displaying 81 - 100 of 806

Sort: Relevancy | Date

Presentation TCT 2023

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

Presenter: Juan Iglesias

October 25, 2023

Presentation TCT 2023

TCT 466: Unintended deformation of stents during bifurcation PCI. An OCTOBER trial substudy

Presenter: Lene Andreasen

October 25, 2023

Presentation TCT 2023

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

Presenter: Giovanni Esposito

October 25, 2023

Presentation TCT 2023

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

Presenter: Pieter Smits

October 25, 2023

Presentation TCT 2023

TCT 565: Drug-Coated Versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated With Provisional Stenting Using Drug-Eluting Stents: Randomized Study

Presenter: MEFTAH Abdelouahed

October 25, 2023

Presentation TCT 2023

TCT 1007: What lesion would you do first/what is the culprit artery ? - Is Drug Eluting Balloon, good as stents?

Presenter: Thisara Samarawickrama

October 25, 2023

Presentation TCT 2023

TCT 815: Treatment of a Giant Coronary Aneurysm With Multiple Covered Stents and Ectatic Coronary Artery Disease With Drug-Coated Balloon

Presenter: Tuomas Rissanen

October 24, 2023

Presentation TCT 2023

Yes: There Is Always Room For Better Stents

Presenter: Abraham Tzafriri

October 24, 2023

Presentation TCT 2023

TCT 229: Effect of delayed hospitalization on patients with non-ST-segment elevation myocardial infarction and complex lesions undergoing successful new-generation drug-eluting stents implantation

Presenter: Yong Hoon Kim

October 24, 2023

Presentation TCT 2023

TCT 351: Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion, 10-year Extended Follow-up Results

Presenter: Seung-Whan Lee

October 24, 2023

Presentation TCT 2023

TCT 60: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry)

Presenter: Wojciech Wanha

October 24, 2023

Presentation Interventional Complications 2023

How to Treat Under-Deployed Stents

Presenter: Kevin J. Croce

July 15, 2023

Presentation TCT 2022

Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

Presenter: Pablo Salinas

September 19, 2022

Presentation TCT 2022

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

Presenter: Jonas Haener

September 19, 2022

Presentation TCT 2022

EXpansion of Stents After Intravascular lithoTripsy vs Conventional Predilatation in CALCified Coronary Arteries

Presenter: Maarten Vink

September 19, 2022

Presentation TCT 2022

Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial

Presenter: Jung-Min Ahn

September 19, 2022

Presentation TCT 2022

TCT 51: Assessment of Durable Polymer and Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction

Presenter: Gustavo Araújo

September 17, 2022

Presentation TCT 2022

Percutaneous CABG - How Many Stents Are Too Many? Implications for Multivessel Stenting

Presenter: Andrew Goldsweig

September 16, 2022

Presentation Interventional Complications 2022

How to Treat Under Deployed Stents

Presenter: Allison B. Hall

July 16, 2022

Presentation CTO 2022

What to Do When Stents Fail: How to Assess and Treat

Presenter: Jennifer Tremmel

February 25, 2022

Advertisement

Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial

TCT 466: Unintended deformation of stents during bifurcation PCI. An OCTOBER trial substudy

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

The Primary Endpoint Results from the COMPARE 60/80 HBR Trial: A Randomized Controlled Multi-Center Trial Comparing Ultrathin With Thin Strut Stents in High Bleeding Risk Patients With an Abbreviated DAPT Duration

TCT 565: Drug-Coated Versus Uncoated Balloon for Side Branch Protection in Coronary Bifurcation Lesions Treated With Provisional Stenting Using Drug-Eluting Stents: Randomized Study

TCT 1007: What lesion would you do first/what is the culprit artery ? - Is Drug Eluting Balloon, good as stents?

TCT 815: Treatment of a Giant Coronary Aneurysm With Multiple Covered Stents and Ectatic Coronary Artery Disease With Drug-Coated Balloon

Yes: There Is Always Room For Better Stents

TCT 229: Effect of delayed hospitalization on patients with non-ST-segment elevation myocardial infarction and complex lesions undergoing successful new-generation drug-eluting stents implantation

TCT 351: Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion, 10-year Extended Follow-up Results

TCT 60: Long-Term Outcomes Following Drug-Coated Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis in Chronic Coronary Syndrome (CCS Dragon-Registry)

How to Treat Under-Deployed Stents

Two-Year Outcomes of the Randomized Second-Generation Drug-Eluting Stents in Diabetes (SUGAR) Trial

TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized…

EXpansion of Stents After Intravascular lithoTripsy vs Conventional Predilatation in CALCified Coronary Arteries

Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial

TCT 51: Assessment of Durable Polymer and Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction

Percutaneous CABG - How Many Stents Are Too Many? Implications for Multivessel Stenting

How to Treat Under Deployed Stents

What to Do When Stents Fail: How to Assess and Treat

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content